TapewireFind a company

person · Reporting owner

Macchiaverna Stephen

Disclosed activity across 1 company

Tapewire entity
87505
SEC CIK
0001623800

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Freshpet, Inc.FRPT · Entity 1637EVP, TreasurerSeptember 12, 2024September 16, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Freshpet, Inc.

Report date September 12, 2024 · Filed September 16, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect86,039 Ending reported balance After 2024-09-12 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2024-09-12 · Exercise / conversion · Acquired 3,822 · Balance 89,861

Row 2 · 2024-09-12 · Sale · Disposed 3,822 · Balance 86,039

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.06. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.

Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $49.77 · Expires 2029-10-01Direct5,500 Reported balance After 2024-09-12 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2024-09-12 · Exercise / conversion · Disposed 3,822 · Balance 5,500

F2: The stock options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan, and vested on December 31, 2022.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.06. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.

F2: The stock options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan, and vested on December 31, 2022.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 30, 2016 Filed Jan 4, 2017 23:02 UTC Freshpet, Inc. FRPT · Entity 1637 GrantOption to Purchase Common Stock · Derivative 35,414 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001437749-17-000185 · rdgdoc.xml · derivative · entry 1

Macchiaverna Stephen · CIK 0001623800 · Sr. VP, Controller, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,414

Underlying: Common Stock · 35,414 shares

Expires 2020-12-31

F1 · derivative.exercise_date: The options were originally issued pursuant to the Issuer's 2010 Stock Option Plan as performance based awards. On December 30, 2016, the awards were amended from performance based awards to time vested awards. The awards as amended vest on December 30, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.